Associate Director
Arrowhead Pharmaceuticals
Associate Director
Arrowhead Pharmaceuticals
Develops RNAi-based gene-silencing therapies
Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.
Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. The depth and versatility of our RNAi technologies enables us to potentially address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics. Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.
Arrowhead’s corporate headquarters is in Pasadena, CA with research and development teams in Madison, WI & San Diego, CA, and a state of the art manufacturing facility in Verona, WI. Our employees are nimble, science-driven innovators who are collaborating to bring new therapies to patients in need.
The Position
Let’s do something amazing together! The Associate Director of Medical Value, Evidence, and Outcomes (MVEO) will support the development and execution of medical value evidence strategies for Arrowhead’s cardiometabolic portfolio, including plozasiran, an investigational siRNA therapeutic targeting APOC3. This role will contribute to evidence generation, real-world evidence initiatives, payer-focused scientific communication, and cross-functional medical affairs planning to support development and commercialization objectives.
The Associate Director of MVEO will report to the Executive Director, Evidence Generation and Dissemination, and work closely with the Medical Value, Evidence, and Outcomes lead and with partners across Medical Affairs, Market Access, Clinical Development, Biometrics, and Regulatory. The position will help translate clinical, epidemiologic, economic, and real-world data into medically rigorous materials and insights that support evidence-based decision-making and stakeholder engagement.
This role is based in Pasadena with an expectation to be in office 5 days a week.
Depending on experience, this role may be hired at the Sr. Manager level.
Responsibilities
Requirements
Preferred
Arrowhead provides competitive salaries and an excellent benefit package.
Candidates must have current, valid authorization to work in the country where this role is located.
California pay range 180000 - 210000 USD
Develops RNAi-based gene-silencing therapies
Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.
Explore more opportunities at Arrowhead Pharmaceuticals